Drug intelligence / Profile preview

ABCD

Development stage: Preclinical
Modality: Small Molecules

Overview

ABCD is a chemotherapy regimen used as an induction treatment for newly diagnosed multiple myeloma. It is a combination of pharmaceutical drugs, though the specific components of the regimen are not detailed in the provided context. The regimen is currently being investigated in clinical trials for its application in this disease.

Other names: ABCD regimenABCD Chemotherapy

Beyond the preview

Go deeper on ABCD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABCD.

Explore the full profile